NASDAQ:CUTR - Cutera Stock Price, Price Target & More

$51.30 0.00 (0.00 %)
(As of 04/23/2018 09:00 AM ET)
Previous Close$51.30
Today's Range$51.10 - $52.00
52-Week Range$18.50 - $55.00
Volume122,600 shs
Average Volume174,758 shs
Market Capitalization$696.81 million
P/E Ratio67.50
Dividend YieldN/A
Beta0.45

About Cutera (NASDAQ:CUTR)

Cutera logoCutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; solera console platform, including Opus and Titan consoles; and CoolGlide systems, as well as provides myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; skin care products; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:CUTR
CUSIPN/A
Phone415-657-5500

Debt

Debt-to-Equity RatioN/A
Current Ratio2.04%
Quick Ratio1.38%

Price-To-Earnings

Trailing P/E Ratio67.50
Forward P/E Ratio84.10
P/E Growth2

Sales & Book Value

Annual Sales$151.49 million
Price / Sales4.60
Cash Flow$0.8851 per share
Price / Cash57.96
Book Value$4.68 per share
Price / Book10.96

Profitability

EPS (Most Recent Fiscal Year)$0.77
Net Income$29.99 million
Net Margins19.80%
Return on Equity18.31%
Return on Assets11.39%

Miscellaneous

Employees367
Outstanding Shares13,580,000

How to Become a New Pot Stock Millionaire

Cutera (NASDAQ:CUTR) Frequently Asked Questions

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

How will Cutera's stock buyback program work?

Cutera declared that its board has authorized a share buyback plan on Tuesday, August 8th 2017, which authorizes the company to repurchase $25,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its shares are undervalued.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) released its quarterly earnings data on Wednesday, February, 14th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.09. The medical device company had revenue of $47.60 million for the quarter, compared to analyst estimates of $43.96 million. Cutera had a return on equity of 18.31% and a net margin of 19.80%. Cutera's revenue was up 25.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.30 EPS. View Cutera's Earnings History.

When is Cutera's next earnings date?

Cutera is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Cutera.

What guidance has Cutera issued on next quarter's earnings?

Cutera issued an update on its FY18 earnings guidance on Wednesday, February, 14th. The company provided earnings per share (EPS) guidance of $1.03-1.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.00. The company issued revenue guidance of $178-181 million, compared to the consensus revenue estimate of $166.90 million.

What price target have analysts set for CUTR?

6 equities research analysts have issued twelve-month price objectives for Cutera's shares. Their predictions range from $32.00 to $60.00. On average, they anticipate Cutera's share price to reach $45.40 in the next twelve months. View Analyst Ratings for Cutera.

What are Wall Street analysts saying about Cutera stock?

Here are some recent quotes from research analysts about Cutera stock:
  • 1. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (4/18/2018)
  • 2. Gabelli analysts commented, "As a leading laser dermatology company, Cutera is an attractive long-term investment as management focuses on execution, growing sales and improving operating performance. Throughout 2017, Cutera revamped several members of its management team, including its CEO and CFO, along with several new hires to build out its sales and operational infrastructure in the US and internationally. Management is putting in place new processes to improve upon product development and scale up its organization for sustainable growth." (2/16/2018)
  • 3. Maxim Group analysts commented, "3Q17 total revenue of $38.2M, up 26.1% y/y, was above both our estimate of $35.6M and consensus of $34.7M. North America product revenue grew 57.4% y/y, while international product revenue grew just 0.1% y/y." (11/8/2017)

Who are some of Cutera's key competitors?

Who are Cutera's key executives?

Cutera's management team includes the folowing people:
  • Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 47)
  • Mr. Ronald J. Santilli, Exec. Officer (Age 58)
  • Mr. James A. Reinstein, CEO, Pres & Director (Age 53)
  • Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 52)
  • Dr. Michael Karavitis Ph.D., Exec. VP & Chief Technology Officer

Has Cutera been receiving favorable news coverage?

Headlines about CUTR stock have trended somewhat positive on Monday, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cutera earned a media sentiment score of 0.14 on Accern's scale. They also assigned media coverage about the medical device company an impact score of 47.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $51.30.

How big of a company is Cutera?

Cutera has a market capitalization of $696.81 million and generates $151.49 million in revenue each year. The medical device company earns $29.99 million in net income (profit) each year or $0.77 on an earnings per share basis. Cutera employs 367 workers across the globe.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]


MarketBeat Community Rating for Cutera (CUTR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  168 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  313
MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe CUTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUTR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cutera (NASDAQ:CUTR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Cutera in the last 12 months. Their average twelve-month price target is $45.40, suggesting that the stock has a possible downside of 11.50%. The high price target for CUTR is $60.00 and the low price target for CUTR is $32.00. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.802.752.75
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $45.40$43.00$37.3333$37.3333
Price Target Upside: 11.50% downside15.02% downside4.15% downside5.37% downside

Cutera (NASDAQ:CUTR) Consensus Price Target History

Price Target History for Cutera (NASDAQ:CUTR)

Cutera (NASDAQ:CUTR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/16/2018Stifel NicolausInitiated CoverageHold -> Hold$55.00HighView Rating Details
3/13/2018StephensInitiated CoverageOverweight$60.00HighView Rating Details
2/16/2018GabelliReiterated RatingBuyLowView Rating Details
11/8/2017Maxim GroupReiterated RatingHoldN/AView Rating Details
9/12/2017Roth CapitalBoost Price TargetBuy$41.00 -> $47.00HighView Rating Details
7/7/2017SidotiReiterated RatingBuy$30.00 -> $32.00MediumView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Cutera (NASDAQ:CUTR) Earnings History and Estimates Chart

Earnings by Quarter for Cutera (NASDAQ:CUTR)

Cutera (NASDAQ:CUTR) Earnings Estimates

Current Year EPS Consensus Estimate: $0.61 EPS
Next Year EPS Consensus Estimate: $1.01 EPS

Cutera (NASDAQ CUTR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018$0.01N/AView Earnings Details
2/14/2018Q4 2017$0.33$0.42$43.96 million$47.60 millionViewListenView Earnings Details
11/7/2017Q3 2017$0.08$0.42$34.82 million$38.17 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.03$0.13$32.08 million$36.40 millionViewListenView Earnings Details
5/1/2017Q1 2017($0.07)($0.07)$29.00 million$29.30 millionViewListenView Earnings Details
2/13/2017Q4 2016$0.27$0.30$38.00 million$37.90 millionViewListenView Earnings Details
11/7/2016Q3$0.04$0.12$28.84 million$30.30 millionViewListenView Earnings Details
8/1/2016Q2($0.01)$0.07$26.20 million$27.50 millionViewListenView Earnings Details
5/2/2016Q1($0.12)($0.16)$21.62 million$22.40 millionViewListenView Earnings Details
2/8/2016Q4$0.11$0.25$29.59 million$30.00 millionViewListenView Earnings Details
11/2/2015Q315($0.12)($0.07)$21.87 million$23.10 millionViewListenView Earnings Details
8/5/2015Q215($0.13)($0.13)$21.41 million$22.56 millionViewListenView Earnings Details
5/7/2015Q115($0.13)($0.25)$18.70 million$19.07 millionViewListenView Earnings Details
2/5/2015Q414$0.08($0.01)$24.56 million$25.50 millionViewListenView Earnings Details
11/3/2014Q314($0.13)($0.18)$18.10 million$18.70 millionViewListenView Earnings Details
8/4/2014Q214($0.08)($0.19)$19.69 million$17.72 millionViewListenView Earnings Details
5/8/2014Q114($0.12)($0.26)$17.02 million$16.20 millionViewListenView Earnings Details
2/11/2014Q413($0.01)($0.02)$21.70 million$22.20 millionViewListenView Earnings Details
11/4/2013Q313($0.03)($0.11)$20.96 million$16.80 millionViewListenView Earnings Details
8/5/2013Q2 2013($0.02)($0.04)$21.70 million$149.60 millionViewListenView Earnings Details
5/6/2013Q1 2013($0.11)($0.15)$18.29 million$15.97 millionViewListenView Earnings Details
2/11/2013Q4 2012$0.02$0.08$22.07 million$22.50 millionViewListenView Earnings Details
11/5/2012Q312($0.11)($0.06)$18.87 million$19.40 millionViewN/AView Earnings Details
8/6/2012($0.10)($0.10)ViewN/AView Earnings Details
5/10/2012($0.26)($0.38)ViewN/AView Earnings Details
2/13/2012($0.08)($0.06)ViewN/AView Earnings Details
11/7/2011($0.16)($0.21)ViewN/AView Earnings Details
8/1/2011($0.20)($0.18)ViewN/AView Earnings Details
5/2/2011($0.15)($0.28)ViewN/AView Earnings Details
2/2/2011($0.12)($0.09)ViewN/AView Earnings Details
11/1/2010Q3 2010($0.18)($0.25)ViewN/AView Earnings Details
8/2/2010Q2 2010($0.09)($0.28)ViewN/AView Earnings Details
5/3/2010Q1 2010($0.05)($0.15)ViewN/AView Earnings Details
11/2/2009Q3 2009($0.06)($0.09)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.08)($0.18)ViewN/AView Earnings Details
5/4/2009Q1 2009($0.06)($0.10)ViewN/AView Earnings Details
2/9/2009Q4 2008$0.01$0.08ViewN/AView Earnings Details
11/3/2008Q3 2008$0.12($0.03)ViewN/AView Earnings Details
8/4/2008Q2 2008$0.11$0.05ViewN/AView Earnings Details
5/6/2008Q1 2008$0.18($0.04)ViewN/AView Earnings Details
2/11/2008Q4 2007$0.40$0.27ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cutera (NASDAQ:CUTR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cutera (NASDAQ CUTR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 96.48%
Insider Trading History for Cutera (NASDAQ:CUTR)
Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Cutera (NASDAQ CUTR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/2/2018James A ReinsteinInsiderSell7,175$45.35$325,386.25132,284View SEC Filing  
1/2/2018Larry LaberEVPSell5,843$45.35$264,980.0579,463View SEC Filing  
12/18/2017David B ApfelbergDirectorSell1,000$47.40$47,400.008,259View SEC Filing  
12/12/2017Miguel PardosEVPSell10,000$46.70$467,000.0039,698View SEC Filing  
11/17/2017David B ApfelbergDirectorSell1,000$42.55$42,550.008,055View SEC Filing  
11/15/2017Larry LaberEVPSell1,250$44.30$55,375.0070,463View SEC Filing  
11/8/2017Larry LaberEVPSell1,700$42.15$71,655.0072,413View SEC Filing  
11/6/2017Larry LaberEVPSell500$41.50$20,750.0072,413View SEC Filing  
11/6/2017Timothy J OsheaDirectorSell4,000$41.00$164,000.0036,467View SEC Filing  
10/18/2017David B ApfelbergDirectorSell1,000$39.90$39,900.0010,259View SEC Filing  
10/16/2017Larry LaberEVPSell500$40.50$20,250.0073,382View SEC Filing  
10/16/2017Timothy J OsheaDirectorSell4,000$39.21$156,840.00View SEC Filing  
9/18/2017David B. ApfelbergDirectorSell1,000$38.45$38,450.00View SEC Filing  
9/11/2017Ronald J SantilliCFOSell5,775$40.43$233,483.2550,012View SEC Filing  
8/30/2017Miguel PardosEVPSell5,000$36.00$180,000.0039,698View SEC Filing  
8/22/2017Ronald J SantilliEVPSell2,947$34.00$100,198.0058,308View SEC Filing  
8/17/2017Ronald J SantilliEVPSell28,519$34.01$969,931.1975,253View SEC Filing  
8/16/2017Ronald J SantilliCFOSell12,000$34.00$408,000.0075,253View SEC Filing  
8/15/2017Ronald J SantilliEVPSell1,068$33.20$35,457.6087,253View SEC Filing  
6/28/2017Larry LaberEVPSell1,000$25.88$25,880.0073,140View SEC Filing  
6/26/2017David A GollnickDirectorSell10,000$25.08$250,800.0026,641View SEC Filing  
6/26/2017Larry LaberEVPSell500$25.50$12,750.0073,140View SEC Filing  
6/16/2017Timothy J OsheaDirectorSell4,000$39.21$156,840.0040,213View SEC Filing  
6/12/2017Larry LaberEVPSell2,563$24.36$62,434.6874,203View SEC Filing  
6/1/2017Larry LaberEVPSell957$22.95$21,963.1576,203View SEC Filing  
6/1/2017Ronald J SantilliCFOSell3,857$22.95$88,518.1588,321View SEC Filing  
5/25/2017Larry LaberEVPSell6,482$22.89$148,372.9880,642View SEC Filing  
5/24/2017David A GollnickDirectorSell39,204$22.31$874,641.2434,136View SEC Filing  
5/9/2017Ronald J SantilliCFOSell20,856$19.90$415,034.4092,178View SEC Filing  
5/8/2017Ronald J SantilliCFOSell60,991$19.99$1,219,210.09174,025View SEC Filing  
4/24/2017Larry LaberEVPSell6,824$20.66$140,983.8482,100View SEC Filing  
4/20/2017Miguel PardosEVPSell5,000$21.00$105,000.0044,698View SEC Filing  
4/19/2017Larry LaberEVPSell2,176$20.54$44,695.0478,852View SEC Filing  
4/10/2017Miguel PardosEVPSell5,000$20.00$100,000.0044,698View SEC Filing  
4/3/2017Miguel PardosEVPSell5,000$20.73$103,650.0044,698View SEC Filing  
3/13/2017J Daniel PlantsDirectorSell250,000$20.25$5,062,500.005,550View SEC Filing  
3/3/2017David A GollnickDirectorSell25,000$20.40$510,000.0073,340View SEC Filing  
2/21/2017Larry LaberEVPSell1,500$21.97$32,955.0072,665View SEC Filing  
11/30/2016David A GollnickDirectorSell17,914$17.01$304,717.1499,940View SEC Filing  
11/14/2016Ronald J SantilliCEOSell53,346$14.05$749,511.30125,958View SEC Filing  
6/7/2016Kevin P ConnorsCEOSell21,606$10.29$222,325.74657,484View SEC Filing  
6/2/2016Kevin P ConnorsCEOSell33,098$10.58$350,176.84645,478View SEC Filing  
5/4/2016Kevin P ConnorsCEOSell65,296$11.37$742,415.52686,001View SEC Filing  
5/3/2016Kevin P ConnorsCEOSell13,172$11.45$150,819.40686,001View SEC Filing  
5/2/2016Kevin P ConnorsCEOSell42,123$11.32$476,832.36686,001View SEC Filing  
3/4/2016Jerry P WidmanDirectorSell12,000$12.01$144,120.0043,723View SEC Filing  
9/4/2015Ronald J. SantilliCFOSell31,599$15.00$473,985.0071,945View SEC Filing  
8/18/2015Ronald J. SantilliCFOSell5,459$15.02$81,994.1871,945View SEC Filing  
8/17/2015Ronald J SantilliCFOSell17,942$15.02$269,488.84View SEC Filing  
6/22/2015David A GollnickDirectorSell6,448$15.04$96,977.92View SEC Filing  
6/8/2015Jerry P WidmanDirectorSell10,000$14.95$149,500.00View SEC Filing  
6/3/2015David A GollnickDirectorSell12,212$15.00$183,180.00View SEC Filing  
6/3/2015Ronald J SantilliCFOSell31,752$14.99$475,962.48View SEC Filing  
6/2/2015David B ApfelbergDirectorSell10,000$14.99$149,900.00View SEC Filing  
6/2/2015Ronald J SantilliCFOSell4,192$15.00$62,880.00View SEC Filing  
6/1/2015David A GollnickDirectorSell15,406$15.00$231,090.00View SEC Filing  
6/1/2015Kevin P ConnorsCEOSell5,010$14.90$74,649.00View SEC Filing  
6/1/2015Ronald J SantilliCFOSell19,663$14.98$294,551.74View SEC Filing  
5/12/2015David B ApfelbergDirectorSell7,000$14.08$98,560.00View SEC Filing  
4/24/2015David A GollnickDirectorSell1,961$14.17$27,787.37View SEC Filing  
4/13/2015Kevin P ConnorsCEOSell33,596$13.41$450,522.36View SEC Filing  
3/30/2015Kevin P ConnorsCEOSell99,704$13.11$1,307,119.44View SEC Filing  
3/9/2015Jerry P WidmanDirectorSell7,000$13.12$91,840.00View SEC Filing  
3/2/2015Ronald J SantilliCFOSell63,700$13.35$850,395.00View SEC Filing  
2/24/2015Clinton SeversonDirectorBuy4,000$12.50$50,000.00View SEC Filing  
2/22/2013David B ApfelbergDirectorSell16,211$12.55$203,448.05View SEC Filing  
8/23/2012Timothy J OsheaDirectorSell2,700$7.47$20,169.00View SEC Filing  
8/21/2012Kevin P ConnorsCEOBuy12,000$7.29$87,480.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cutera (NASDAQ CUTR) News Headlines

Source:
DateHeadline
Cutera (CUTR) Upgraded to Strong-Buy by BidaskClubCutera (CUTR) Upgraded to Strong-Buy by BidaskClub
www.americanbankingnews.com - April 19 at 11:03 AM
Zacks Investment Research Downgrades Cutera (CUTR) to HoldZacks Investment Research Downgrades Cutera (CUTR) to Hold
www.americanbankingnews.com - April 18 at 10:16 PM
Cutera (CUTR) Research Coverage Started at Stifel NicolausCutera (CUTR) Research Coverage Started at Stifel Nicolaus
www.americanbankingnews.com - April 16 at 5:24 PM
Cutera (CUTR) Downgraded to "Hold" at BidaskClubCutera (CUTR) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - April 14 at 7:21 AM
Head to Head Comparison: Cutera (CUTR) and Its PeersHead to Head Comparison: Cutera (CUTR) and Its Peers
www.americanbankingnews.com - April 14 at 1:13 AM
Cutera, Inc. (CUTR) Given Consensus Rating of "Buy" by AnalystsCutera, Inc. (CUTR) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - April 13 at 1:41 AM
Cutera Celebrates 20 Years of Best-In-Class Product InnovationCutera Celebrates 20 Years of Best-In-Class Product Innovation
finance.yahoo.com - April 12 at 8:33 AM
Cutera, Inc. to Announce First Quarter 2018 ResultsCutera, Inc. to Announce First Quarter 2018 Results
finance.yahoo.com - April 11 at 8:27 AM
Financial Review: Cutera (CUTR) vs. Its RivalsFinancial Review: Cutera (CUTR) vs. Its Rivals
www.americanbankingnews.com - April 10 at 9:14 PM
Critical Review: Cutera (CUTR) & The CompetitionCritical Review: Cutera (CUTR) & The Competition
www.americanbankingnews.com - April 8 at 1:17 AM
Cutera (CUTR) Upgraded by BidaskClub to "Strong-Buy"Cutera (CUTR) Upgraded by BidaskClub to "Strong-Buy"
www.americanbankingnews.com - April 7 at 7:02 AM
Critical Review: Masimo (MASI) vs. Cutera (CUTR)Critical Review: Masimo (MASI) vs. Cutera (CUTR)
www.americanbankingnews.com - April 3 at 3:12 PM
Cutera (CUTR) & Its Rivals Financial ComparisonCutera (CUTR) & Its Rivals Financial Comparison
www.americanbankingnews.com - April 2 at 5:28 AM
Edited Transcript of CUTR earnings conference call or presentation 14-Feb-18 9:30pm GMTEdited Transcript of CUTR earnings conference call or presentation 14-Feb-18 9:30pm GMT
finance.yahoo.com - April 1 at 8:17 AM
Head to Head Analysis: Cutera (CUTR) and Its RivalsHead to Head Analysis: Cutera (CUTR) and Its Rivals
www.americanbankingnews.com - March 31 at 5:10 PM
Financial Review: MTS Systems (MTSC) versus Cutera (CUTR)Financial Review: MTS Systems (MTSC) versus Cutera (CUTR)
www.americanbankingnews.com - March 30 at 1:34 AM
Cutera (CUTR) Stock Rating Lowered by BidaskClubCutera (CUTR) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - March 29 at 11:29 AM
Critical Comparison: Cutera (CUTR) & Its RivalsCritical Comparison: Cutera (CUTR) & Its Rivals
www.americanbankingnews.com - March 27 at 7:22 PM
Cutera (CUTR) versus Its Rivals Financial SurveyCutera (CUTR) versus Its Rivals Financial Survey
www.americanbankingnews.com - March 25 at 9:22 AM
Cutera (CUTR) versus Lumentum (LITE) Financial ContrastCutera (CUTR) versus Lumentum (LITE) Financial Contrast
www.americanbankingnews.com - March 21 at 5:33 PM
Cutera to Present at the Sidoti Spring 2018 Investor ConferenceCutera to Present at the Sidoti Spring 2018 Investor Conference
finance.yahoo.com - March 20 at 8:24 AM
Financial Survey: Cutera (CUTR) vs. The CompetitionFinancial Survey: Cutera (CUTR) vs. The Competition
www.americanbankingnews.com - March 19 at 11:50 AM
Cutera, Inc. (CUTR) Receives Average Recommendation of "Buy" from BrokeragesCutera, Inc. (CUTR) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 19 at 1:53 AM
Stephens Begins Coverage on Cutera (CUTR)Stephens Begins Coverage on Cutera (CUTR)
www.americanbankingnews.com - March 18 at 11:15 AM
BidaskClub Upgrades Cutera (CUTR) to Strong-BuyBidaskClub Upgrades Cutera (CUTR) to Strong-Buy
www.americanbankingnews.com - March 17 at 6:44 PM
BRIEF-Cutera Inc Files For Non-Timely 10-K - SEC FilingBRIEF-Cutera Inc Files For Non-Timely 10-K - SEC Filing
www.reuters.com - March 17 at 8:23 AM
Cutera (CUTR) Presents At 38th Annual Cowen And Company Healthcare Conference - SlideshowCutera (CUTR) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
seekingalpha.com - March 17 at 8:23 AM
Cutera, Inc. (CUTR) Holdings Trimmed by Martingale Asset Management L PCutera, Inc. (CUTR) Holdings Trimmed by Martingale Asset Management L P
www.americanbankingnews.com - March 4 at 12:50 PM
Cutera, Inc. (CUTR) Shares Bought by Bogle Investment Management L P DECutera, Inc. (CUTR) Shares Bought by Bogle Investment Management L P DE
www.americanbankingnews.com - March 3 at 4:52 AM
Cortina Asset Management LLC Purchases New Stake in Cutera, Inc. (CUTR)Cortina Asset Management LLC Purchases New Stake in Cutera, Inc. (CUTR)
www.americanbankingnews.com - March 2 at 1:32 PM
Spark Investment Management LLC Decreases Position in Cutera, Inc. (CUTR)Spark Investment Management LLC Decreases Position in Cutera, Inc. (CUTR)
www.americanbankingnews.com - February 27 at 4:35 PM
EAM Investors LLC Sells 45,993 Shares of Cutera, Inc. (CUTR)EAM Investors LLC Sells 45,993 Shares of Cutera, Inc. (CUTR)
www.americanbankingnews.com - February 27 at 3:00 PM
Cutera, Inc. (CUTR) Holdings Lessened by Fuller & Thaler Asset Management Inc.Cutera, Inc. (CUTR) Holdings Lessened by Fuller & Thaler Asset Management Inc.
www.americanbankingnews.com - February 27 at 1:06 PM
Cutera, Inc. (CUTR) Receives Consensus Recommendation of "Buy" from AnalystsCutera, Inc. (CUTR) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 22 at 1:42 AM
Cutera (CUTR) Upgraded at Zacks Investment ResearchCutera (CUTR) Upgraded at Zacks Investment Research
www.americanbankingnews.com - February 21 at 10:00 PM
Cutera, Inc. to Post FY2022 Earnings of $2.30 Per Share, Gabelli Forecasts (CUTR)Cutera, Inc. to Post FY2022 Earnings of $2.30 Per Share, Gabelli Forecasts (CUTR)
www.americanbankingnews.com - February 19 at 9:34 AM
Gabelli Reaffirms Buy Rating for Cutera (CUTR)Gabelli Reaffirms Buy Rating for Cutera (CUTR)
www.americanbankingnews.com - February 16 at 4:20 PM
Cuteras (CUTR) CEO James Reinstein on Q4 2017 Results - Earnings Call TranscriptCutera's (CUTR) CEO James Reinstein on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - February 15 at 5:22 PM
Cutera (CUTR) Releases  Earnings Results, Beats Estimates By $0.09 EPSCutera (CUTR) Releases Earnings Results, Beats Estimates By $0.09 EPS
www.americanbankingnews.com - February 15 at 10:08 AM
Cutera Reports Fourth Quarter and Full Year 2017 Record Revenue and Financial ResultsCutera Reports Fourth Quarter and Full Year 2017 Record Revenue and Financial Results
finance.yahoo.com - February 15 at 9:44 AM
Cutera Showcases Expanded Portfolio at AADCutera Showcases Expanded Portfolio at AAD
finance.yahoo.com - February 15 at 9:44 AM
Cutera (CUTR) Issues FY18 Earnings GuidanceCutera (CUTR) Issues FY18 Earnings Guidance
www.americanbankingnews.com - February 14 at 5:46 PM
Cutera (CUTR) Scheduled to Post Earnings on MondayCutera (CUTR) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - February 5 at 3:26 AM
Cutera, Inc. (CUTR) Receives Average Recommendation of "Buy" from AnalystsCutera, Inc. (CUTR) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 28 at 1:50 AM
Commit To Buy Cutera At $45, Earn 16.5% Annualized Using OptionsCommit To Buy Cutera At $45, Earn 16.5% Annualized Using Options
www.nasdaq.com - January 23 at 5:26 PM
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2017 ResultsCutera, Inc. to Announce Fourth Quarter and Full-Year 2017 Results
finance.yahoo.com - January 17 at 9:59 AM
Short Interest in Cutera, Inc. (CUTR) Grows By 33.4%Short Interest in Cutera, Inc. (CUTR) Grows By 33.4%
www.americanbankingnews.com - January 14 at 2:34 AM
Cutera (CUTR) Stock Rating Upgraded by Zacks Investment ResearchCutera (CUTR) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - January 9 at 8:58 PM
Cutera Enters Two New Aesthetic Markets With Launch Of New ProductsCutera Enters Two New Aesthetic Markets With Launch Of New Products
www.prnewswire.com - January 8 at 9:25 AM
Larry Laber Sells 5,843 Shares of Cutera, Inc. (CUTR) StockLarry Laber Sells 5,843 Shares of Cutera, Inc. (CUTR) Stock
www.americanbankingnews.com - January 4 at 7:56 PM

SEC Filings

Cutera (NASDAQ:CUTR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cutera (NASDAQ:CUTR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cutera (NASDAQ CUTR) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.